Abanades S - Search Results

1

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.

de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J. de la Torre R, et al. Among authors: abanades s. Ther Drug Monit. 2004 Apr;26(2):137-44. doi: 10.1097/00007691-200404000-00009. Ther Drug Monit. 2004. PMID: 15228154 Review.

2

Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring.

Abanades S, Farré M, Segura M, Pichini S, Pastor A, Pacifici R, Pellegrini M, de la Torre R. Abanades S, et al. Ther Drug Monit. 2007 Feb;29(1):64-70. doi: 10.1097/FTD.0b013e3180307e5e. Ther Drug Monit. 2007. PMID: 17304152 Clinical Trial.

3

Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.

Farré M, Abanades S, Roset PN, Peiró AM, Torrens M, O'Mathúna B, Segura M, de la Torre R. Farré M, et al. Among authors: abanades s. J Pharmacol Exp Ther. 2007 Dec;323(3):954-62. doi: 10.1124/jpet.107.129056. Epub 2007 Sep 21. J Pharmacol Exp Ther. 2007. PMID: 17890444 Clinical Trial.

4

Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.

Abanades S, Farré M, Segura M, Pichini S, Barral D, Pacifici R, Pellegrini M, Fonseca F, Langohr K, De La Torre R. Abanades S, et al. Ann N Y Acad Sci. 2006 Aug;1074:559-76. doi: 10.1196/annals.1369.065. Ann N Y Acad Sci. 2006. PMID: 17105953 Clinical Trial.

5

The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans.

O'Mathúna B, Farré M, Rostami-Hodjegan A, Yang J, Cuyàs E, Torrens M, Pardo R, Abanades S, Maluf S, Tucker GT, de la Torre R. O'Mathúna B, et al. Among authors: abanades s. J Clin Psychopharmacol. 2008 Oct;28(5):523-9. doi: 10.1097/JCP.0b013e318184ff6e. J Clin Psychopharmacol. 2008. PMID: 18794647 Clinical Trial.

6

Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.

Abanades S, Farré M, Barral D, Torrens M, Closas N, Langohr K, Pastor A, de la Torre R. Abanades S, et al. J Clin Psychopharmacol. 2007 Dec;27(6):625-38. doi: 10.1097/jcp.0b013e31815a2542. J Clin Psychopharmacol. 2007. PMID: 18004131 Clinical Trial.

7

[Study of the extent and rate of bioavailability of ibuprofen tablets].

Farré M, Roset PN, Pascual JA, Abanades S, Menoyo E, Alvarez Y, Baena A. Farré M, et al. Among authors: abanades s. Reumatol Clin. 2005 Oct;1(3):155-60. doi: 10.1016/S1699-258X(05)72735-2. Epub 2008 Dec 20. Reumatol Clin. 2005. PMID: 21794255 Free article. Spanish.

8

[Club drugs: old medicines as new party drugs].

Abanades S, Peiró AM, Farré M. Abanades S, et al. Med Clin (Barc). 2004 Sep 11;123(8):305-11. doi: 10.1016/s0025-7753(04)74499-1. Med Clin (Barc). 2004. PMID: 15373979 Review. Spanish.

9

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R. de Sola Llopis S, et al. Among authors: abanades s. J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545. Epub 2008 Jan 21. J Psychopharmacol. 2008. PMID: 18208910

10

Study of paracetamol 1-g oral solution bioavailability.

Farre M, Roset PN, Abanades S, Menoyo E, Alvarez Y, Rovira M, Baena A. Farre M, et al. Among authors: abanades s. Methods Find Exp Clin Pharmacol. 2008 Jan-Feb;30(1):37-41. doi: 10.1358/mf.2008.30.1.1159648. Methods Find Exp Clin Pharmacol. 2008. PMID: 18389096 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page